Co-infection of influenza virus and SARS-CoV-2 can lead to more severe disease than infection of either alone.
The current reality is one of verified, world-class innovation that positions Uganda as a hub for advanced biotechnology ...
In the realm of medical advancements, a universal vaccine that can protect against any pathogen has long been a Holy Grail - and about as elusive as a mythological vessel.But Stanford ...
COVID-19 vaccinations were shown to reduce virus-related hospitalizations and severe disease-associated outcomes in immunocompetent adults. The findings from a recently published JAMA Network Open ...
A groundbreaking study explains why certain COVID-19 vaccines caused dangerous blood clots, hemorrhages and VITT syndrome, ...
COVID-19 vaccination during the 2024-2025 respiratory virus season was associated with protection against hospitalization.
A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...
Engineered M13 phage-based biosensor offers rapid, label-free detection of SARS-CoV-2 spike protein, demonstrating ...
Morning Overview on MSN
New nasal vaccine shields lungs for months from viruses, bacteria, and allergens
Stanford Medicine researchers have developed an experimental nasal vaccine that shielded mouse lungs for at least three months against a striking range of respiratory threats, from SARS-CoV-2 and ...
Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common ...
A review published in Infection highlights viral mimic systems that safely replicate key features of pathogens like SARS-CoV-2. These technologies allow vaccine testing in lower-level biosafety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results